CVS Health will separate its retail pharmacies into a new entity in 2028, ending its era as a diversified healthcare conglomerate. The move will leave the company focused on insurance and pharmacy benefits operations, which are expected to generate steady revenue streams. Executives say the split will allow each business to pursue distinct growth strategies and better serve customers.
Analysts view the restructuring as a response to competitive pressures and regulatory challenges in the pharmacy sector. The new pharmacy company will operate independently, while CVS Health continues to expand its benefits and insurance offerings. The timing aligns with the company's long‑term roadmap to streamline its portfolio and enhance shareholder value.
Investors are watching for details on valuation, integration plans, and the impact on future earnings as the split approaches.
Source: New York Times Top Stories · Summarized by HeadlinesBriefing